In Charts: Seed Deals Keep Getting Bigger As Odds Of Reaching Series A Fall Dramatically

Why It Matters

Larger seed checks raise the capital bar but also increase dilution and risk, while slower progression to Series A squeezes runway and forces VCs to rethink portfolio sizing and follow‑on reserves.

Key Takeaways

• Median U.S. seed round hit $3 million in 2025, three‑fold since 2018.
• Top‑quartile seed deals now average $5.6 million, double 2018 levels.
• Series‑A median rose to $15 million, extending the capital gap.
• Time from seed to Series A exceeds two years, slowing growth.
• Only 24% of 2023 $1M‑plus seed firms reached later funding.

Pulse Analysis

The AI‑driven funding surge has reshaped seed economics, pushing median deal sizes to $3 million and top‑quartile rounds above $5 million. Venture firms, flush with capital, are writing larger checks to secure meaningful ownership stakes, a shift driven by heightened competition for promising founders and the perception that early‑stage capital can capture outsized upside. This influx of money has also inflated valuations, making it harder for later‑stage investors to find attractive entry points.

However, the upside comes with a cost. Startups now face a longer runway before their next financing milestone, with the seed‑to‑Series A gap stretching past two years. Investors demand higher proof of traction—ARR targets of $2‑4 million instead of the historic $1 million—forcing founders to burn more cash before securing the next round. The result is a steep drop in graduation rates: only about a quarter of 2023 seed‑backed companies progress, and the figure falls to 16% for the 2024 cohort. This slowdown raises the risk of early failures and puts pressure on founders to demonstrate sustainable growth earlier.

For venture capitalists, the evolving landscape mandates a strategic pivot. Firms must balance larger seed allocations with sufficient reserves for follow‑on investments, potentially reducing the number of bets per fund. Portfolio construction now leans toward a few high‑conviction, larger‑check deals rather than a shotgun approach. While the mortality rate may rise, the upside potential for successful exits could be unprecedented, rewarding investors who can navigate the tighter capital efficiency demands and identify breakout startups amid the heightened competition.